Trial Profile
Extension Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2012
Price :
$35
*
At a glance
- Drugs Semapimod (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 29 Aug 2012 New trial record